Strategic Partnerships BioGenes actively collaborates with global pharma, biotech, CMOs and diagnostic firms and recently expanded partnerships with Gyros Protein Technologies and Sensor Malaysia. Target outreach to potential lab automation partners, contract manufacturers, and regional distributors to co-develop or resell immunoassay kits and HCP solutions.

HCP and ELISA Focus The company specializes in host cell protein (HCP) assays and robust ELISAs, including the 360-HCP ELISA kits, which positions BioGenes well for customers seeking regulatory-compliant analytics in biotherapeutic manufacturing and QC. Pursue opportunities with biopharma and contract manufacturing organizations needing HCP characterization, assay development and validation.

Global Customer Base With over 600 customers across 40 countries, BioGenes demonstrates a broad international footprint and recurring service potential. Leverage this network to upsell service packages, extended analytical services, and training or support contracts for new regional teams and product launches.

Therapeutic and Diagnostic Synergy Capabilities span drug discovery through manufacturing support and diagnostic applications, indicating cross-sell potential into diagnostic labs and translational research groups. Propose bundled solutions combining antibody development, assay optimization, and diagnostic validation for end-to-end workflows.

Growth Readiness Recent announcements of collaborations and a mid-sized revenue base suggest capacity for scaled projects and strategic alliances. Position BioGenes for multi-year engagement opportunities, including platform collaboration, Kit-as-a-Service models, and co-development agreements with larger biotech players looking to accelerate immunoassay and HCP workflows.